Castle Biosciences Inc (CSTL) — Financial Flexibility Index
Castle Biosciences Inc (CSTL) has a Financial Flexibility Index of -0.11x as of March 2026. Free cash flow of $-9.67 Million (operating CF $-22.13 Million minus capex $12.46 Million) represents 0% of total liabilities ($86.39 Million). Check asset allocation strategy of Castle Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Castle Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Castle Biosciences Inc across 9 annual periods. See CSTL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Castle Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Castle Biosciences Inc. For the full company profile including market capitalisation, see Castle Biosciences Inc (CSTL) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | $100.37 Million | $64.35 Million | $107.68 Million | ▼ -24.6% |
| 2024 | 1.24x | $93.19 Million | $64.87 Million | $75.40 Million | ▲ +859.6% |
| 2023 | 0.13x | $8.00 Million | $-5.63 Million | $62.07 Million | ▲ +117.2% |
| 2022 | -0.75x | $-36.02 Million | $-41.66 Million | $48.18 Million | ▼ -145.2% |
| 2021 | -0.30x | $-15.50 Million | $-18.98 Million | $50.83 Million | ▼ -149.3% |
| 2020 | 0.62x | $14.62 Million | $9.87 Million | $23.64 Million | ▲ +169.3% |
| 2019 | 0.23x | $7.95 Million | $7.01 Million | $34.63 Million | ▲ +162.0% |
| 2018 | -0.37x | $-12.02 Million | $-12.29 Million | $32.47 Million | ▲ +24.1% |
| 2017 | -0.49x | $-11.74 Million | $-12.23 Million | $24.09 Million | — |